AP2012006352A0 - AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same. - Google Patents
AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same.Info
- Publication number
- AP2012006352A0 AP2012006352A0 AP2012006352A AP2012006352A AP2012006352A0 AP 2012006352 A0 AP2012006352 A0 AP 2012006352A0 AP 2012006352 A AP2012006352 A AP 2012006352A AP 2012006352 A AP2012006352 A AP 2012006352A AP 2012006352 A0 AP2012006352 A0 AP 2012006352A0
- Authority
- AP
- ARIPO
- Prior art keywords
- same
- derivatives
- pharmaceutical compositions
- compositions containing
- preparing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0905953A FR2953521B1 (fr) | 2009-12-09 | 2009-12-09 | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2010/000823 WO2011070253A1 (fr) | 2009-12-09 | 2010-12-08 | Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2012006352A0 true AP2012006352A0 (en) | 2012-08-31 |
Family
ID=42711699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2012006352A AP2012006352A0 (en) | 2009-12-09 | 2010-12-08 | AzabicycloÄ3.1.0Ühex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same. |
Country Status (32)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016529307A (ja) * | 2013-09-09 | 2016-09-23 | サノフイ | アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| ATE466007T1 (de) * | 2005-11-30 | 2010-05-15 | Hoffmann La Roche | 5-substituierte indol-2-carbonsäureamidderivate |
-
2009
- 2009-12-09 FR FR0905953A patent/FR2953521B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-01 UY UY0001033072A patent/UY33072A/es unknown
- 2010-12-03 TW TW099142190A patent/TW201200499A/zh unknown
- 2010-12-06 AR ARP100104484A patent/AR079265A1/es not_active Application Discontinuation
- 2010-12-07 SA SA110320011A patent/SA110320011B1/ar unknown
- 2010-12-08 UA UAA201208178A patent/UA102950C2/ru unknown
- 2010-12-08 US US13/514,796 patent/US20120283245A1/en not_active Abandoned
- 2010-12-08 CN CN2010800559947A patent/CN102652127A/zh active Pending
- 2010-12-08 AP AP2012006352A patent/AP2012006352A0/xx unknown
- 2010-12-08 CA CA2782469A patent/CA2782469C/fr not_active Expired - Fee Related
- 2010-12-08 EA EA201200849A patent/EA201200849A1/ru unknown
- 2010-12-08 WO PCT/FR2010/000823 patent/WO2011070253A1/fr not_active Ceased
- 2010-12-08 AU AU2010329762A patent/AU2010329762B2/en not_active Ceased
- 2010-12-08 BR BR112012013666A patent/BR112012013666A2/pt not_active IP Right Cessation
- 2010-12-08 PH PH1/2012/501053A patent/PH12012501053A1/en unknown
- 2010-12-08 IN IN4966DEN2012 patent/IN2012DN04966A/en unknown
- 2010-12-08 EP EP10799080A patent/EP2509947A1/fr not_active Withdrawn
- 2010-12-08 JP JP2012542591A patent/JP2013513589A/ja not_active Ceased
- 2010-12-08 KR KR1020127017843A patent/KR20120102763A/ko not_active Ceased
- 2010-12-08 SG SG2012038931A patent/SG181082A1/en unknown
- 2010-12-08 PE PE2012000722A patent/PE20121475A1/es not_active Application Discontinuation
- 2010-12-08 GE GEAP201012774A patent/GEP20156227B/en unknown
- 2010-12-08 MX MX2012006578A patent/MX2012006578A/es active IP Right Grant
- 2010-12-08 MA MA34932A patent/MA33882B1/fr unknown
-
2012
- 2012-05-28 TN TNP2012000267A patent/TN2012000267A1/fr unknown
- 2012-05-29 CR CR20120286A patent/CR20120286A/es unknown
- 2012-05-30 ZA ZA2012/03943A patent/ZA201203943B/en unknown
- 2012-06-05 EC ECSP12011950 patent/ECSP12011950A/es unknown
- 2012-06-06 CL CL2012001479A patent/CL2012001479A1/es unknown
- 2012-06-06 CO CO12095636A patent/CO6541535A2/es unknown
- 2012-06-07 CU CU20120091A patent/CU20120091A7/es unknown
- 2012-06-07 NI NI201200099A patent/NI201200099A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL216826A0 (en) | Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same | |
| IL208203A (en) | Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations | |
| AP2012006191A0 (en) | Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same. | |
| IL214175A (en) | Derivatives of aminotetralin, their pharmaceutical compositions and their use | |
| IL205759A (en) | History of isoxazolo-pyridine, a process for their preparation and the drugs containing them | |
| IL216171A (en) | Lipidic Compound, Method for Preparing the Compound, Pharmaceutical and Lipid Preparations Containing Their Composition and Uses | |
| ZA201208198B (en) | Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same | |
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| PL2107055T3 (pl) | Nowe pochodne diosmetyny, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
| ZA201301463B (en) | Pharmaceutical compositions for calonolides,their derivatives and analogues,and process for producing the same | |
| EP2351764A4 (en) | TREHALOSE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PRODUCT CONTAINING THE COMPOUND | |
| IL218539A (en) | Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted | |
| IL216388A0 (en) | New compounds, pharmaceutical composition and methods relating thereto | |
| IL213452A0 (en) | Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof | |
| IL217053A0 (en) | Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
| AP2010005343A0 (en) | New dihydroindolone compounds, a process for theirpreparation and pharmaceutical compositions conta ining them. | |
| IL212942A (en) | History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses | |
| IL186062A (en) | Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| IL217057A0 (en) | Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
| PL2231598T3 (pl) | Nowe pochodne diazeniodiolanów, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające | |
| SI2147915T1 (sl) | Novi cikloalkilirani benzotiadiazinski derivati postopek za njihovo pripravo in farmacevtski sestavki ki jih vsebujejo | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL213792A0 (en) | Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same | |
| IL213588A0 (en) | Naphthyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| PH12012500315A1 (en) | Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same |